CS logo
small CS logo
Centro de Estudios Clínicos SAGA

Santiago, Chile
Health consultant in Providencia, Chile
Antonio Varas 517, Providencia, 7500653, Región Metropolitana

About Centro de Estudios Clínicos SAGA


"Centro de Estudios Clínicos, especializado en Oncología"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Basilea Pharmaceutica
1
Total Rows: 2

Clinical Trials at Centro de Estudios Clínicos SAGA


During the past decade, Centro de Estudios Clínicos SAGA conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years111122000000Started TrialsCompleted Trails2019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
2019-02-07
2026-12-19
Recruiting
3,400
Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma
2020-10-06
2022-12-29
Terminated
47
An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib
2021-05-10
2027-04-09
Recruiting
800
A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
2021-04-26
2025-02-05
Recruiting
554

Rows per page:

1–4 of 4

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 3Hoffmann-La Roche: 3Basilea Pharmaceutica: 1Basilea Pharmaceutica: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Centro de Estudios Clínicos SAGA


According to Clinical.Site data, the most researched conditions in "Centro de Estudios Clínicos SAGA" are "Gastric Adenocarcinoma" (1 trials), "Hepatocellular Carcinoma" (1 trials), "NSCLC" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Centro de Estudios Clínicos SAGA" in a lesser frequency.

Clinical Trials Intervention Types at Centro de Estudios Clínicos SAGA


Most popular intervention types in "Centro de Estudios Clínicos SAGA" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Alectinib" (1 trials), "Derazantinib" (1 trials), "Derazantinib-atezolizumab" (1 trials) and "Derazantinib-paclitaxel-ramucirumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Centro de Estudios Clínicos SAGA


The vast majority of trials in "Centro de Estudios Clínicos SAGA" are 4 trials for "All" genders.

Clinical Trials Status at Centro de Estudios Clínicos SAGA


Currently, there are NaN active trials in "Centro de Estudios Clínicos SAGA". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centro de Estudios Clínicos SAGA, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Centro de Estudios Clínicos SAGA, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 1: 1Phase 1: 1Phase 2: 1Phase 2: 1Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 3Recruiting: 3Terminated: 1Terminated: 1